{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T18:50:11Z","timestamp":1790275811924,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Government of India Department of Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004507","name":"CSIR-Central Drug Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.lfs.2021.119193","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T13:04:48Z","timestamp":1612875888000},"page":"119193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["6,7-Dihydroxycoumarin ameliorates crystal-induced necroptosis during crystal nephropathies by inhibiting MLKL phosphorylation"],"prefix":"10.1016","volume":"271","author":[{"given":"Smita","family":"Prajapati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhawna","family":"Tomar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogesh B.","family":"Narkhede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil N.","family":"Gaikwad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Lahiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrikant R.","family":"Mulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.lfs.2021.119193_bb0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrneph.2016.101","article-title":"Idiopathic hypercalciuria and formation of calcium renal stones","volume":"12","author":"Coe","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"issue":"4","key":"10.1016\/j.lfs.2021.119193_bb0010","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrneph.2017.10","article-title":"Crystal nephropathies: mechanisms of crystal-induced kidney injury","volume":"13","author":"Mulay","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.lfs.2021.119193_bb0015","doi-asserted-by":"crossref","unstructured":"Cochat, P. and G. Rumsby, Primary hyperoxaluria. N. Engl. J. Med., 2013. 369(7): p. 649\u201358.","DOI":"10.1056\/NEJMra1301564"},{"issue":"4","key":"10.1016\/j.lfs.2021.119193_bb0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MNH.0000000000000229","article-title":"Oxalate, inflammasome, and progression of kidney disease","volume":"25","author":"Ermer","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.lfs.2021.119193_bb0025","doi-asserted-by":"crossref","unstructured":"Vervaet, B.A., et al., Nephrocalcinosis: new insights into mechanisms and consequences. Nephrol. Dial. Transplant., 2009. 24(7): p. 2030\u20135.","DOI":"10.1093\/ndt\/gfp115"},{"issue":"4","key":"10.1016\/j.lfs.2021.119193_bb0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00240-019-01125-1","article-title":"Hydroxycitrate: a potential new therapy for calcium urolithiasis","volume":"47","author":"Kim","year":"2019","journal-title":"Urolithiasis"},{"issue":"6","key":"10.1016\/j.lfs.2021.119193_bb0035","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1172\/JCI99822","article-title":"Stiripentol protects against calcium oxalate nephrolithiasis and ethylene glycol poisoning","volume":"129","author":"Le Dudal","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.lfs.2021.119193_bb0040","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/ki.2013.104","article-title":"The role of Oxalobacter formigenes colonization in calcium oxalate stone disease","volume":"83","author":"Siener","year":"2013","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2021.119193_bb0045","doi-asserted-by":"crossref","unstructured":"Kletzmayr, A., et al., Inhibitors of calcium oxalate crystallization for the treatment of oxalate nephropathies. Adv Sci (Weinh), 2020. 7(8): p. 1903337.","DOI":"10.1002\/advs.201903337"},{"issue":"3","key":"10.1016\/j.lfs.2021.119193_bb0050","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1681\/ASN.2016040486","article-title":"Hyperoxaluria requires TNF receptors to initiate crystal adhesion and kidney stone disease","volume":"28","author":"Mulay","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119193_bb0055","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI63679","article-title":"Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1beta secretion","volume":"123","author":"Mulay","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.lfs.2021.119193_bb0060","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ki.2013.207","article-title":"NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy","volume":"84","author":"Knauf","year":"2013","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.lfs.2021.119193_bb0065","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.kint.2017.09.022","article-title":"The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury","volume":"93","author":"Anders","year":"2018","journal-title":"Kidney Int."},{"key":"10.1016\/j.lfs.2021.119193_bb0070","doi-asserted-by":"crossref","unstructured":"Ludwig-Portugall, I., et al., An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice. Kidney Int., 2016. 90(3): p. 525\u201339.","DOI":"10.1016\/j.kint.2016.03.035"},{"issue":"10","key":"10.1016\/j.lfs.2021.119193_bb0075","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1681\/ASN.2018121218","article-title":"Mitochondria permeability transition versus necroptosis in oxalate-induced AKI","volume":"30","author":"Mulay","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.lfs.2021.119193_bb0080","doi-asserted-by":"crossref","unstructured":"Mulay, S.R., et al., Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis. Nat. Commun., 2016. 7: p. 10274.","DOI":"10.1038\/ncomms10274"},{"issue":"3","key":"10.1016\/j.lfs.2021.119193_bb0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tips.2020.01.002","article-title":"Inhibitors targeting RIPK1\/RIPK3: old and new drugs","volume":"41","author":"Martens","year":"2020","journal-title":"Trends Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2021.119193_bb0090","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","article-title":"The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism","volume":"39","author":"Murphy","year":"2013","journal-title":"Immunity"},{"issue":"42","key":"10.1016\/j.lfs.2021.119193_bb0095","doi-asserted-by":"crossref","first-page":"15072","DOI":"10.1073\/pnas.1408987111","article-title":"Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death","volume":"111","author":"Hildebrand","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.lfs.2021.119193_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.15171\/jrip.2016.27","article-title":"Identification of medicinal plants for the treatment of kidney and urinary stones","volume":"5","author":"Bahmani","year":"2016","journal-title":"J Renal Inj Prev"},{"key":"10.1016\/j.lfs.2021.119193_bb0105","unstructured":"Nasri, H. and H. Shirzad, Toxicity and safety of medicinal plants. J HerbMed Pharmacol, 2013. 2(2): p. 21\u201322."},{"issue":"3","key":"10.1016\/j.lfs.2021.119193_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19030765","article-title":"Dietary plants for the prevention and management of kidney stones: preclinical and clinical evidence and molecular mechanisms","volume":"19","author":"Nirumand","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2021.119193_bb0115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15804-9","article-title":"Phagocytosis of environmental or metabolic crystalline particles induces cytotoxicity by triggering necroptosis across a broad range of particle size and shape","volume":"7","author":"Honarpisheh","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.lfs.2021.119193_bb0120","doi-asserted-by":"crossref","first-page":"F785","DOI":"10.1152\/ajprenal.00488.2015","article-title":"Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL\/6 mice","volume":"310","author":"Mulay","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.lfs.2021.119193_bb0125","doi-asserted-by":"crossref","unstructured":"Chen, Y., et al., Esculetin ameliorates psoriasis-like skin disease in mice by inducing CD4(+)Foxp3(+) regulatory T cells. Front. Immunol., 2018. 9: p. 2092.","DOI":"10.3389\/fimmu.2018.02092"},{"issue":"1","key":"10.1016\/j.lfs.2021.119193_bb0130","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.celrep.2013.08.044","article-title":"Structural insights into RIP3-mediated necroptotic signaling","volume":"5","author":"Xie","year":"2013","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.lfs.2021.119193_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16823-3","article-title":"Distinct pseudokinase domain conformations underlie divergent activation mechanisms among vertebrate MLKL orthologues","volume":"11","author":"Davies","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.lfs.2021.119193_bb0140","doi-asserted-by":"crossref","first-page":"5.6.1","DOI":"10.1002\/0471250953.bi0506s15","article-title":"Comparative protein structure modeling using Modeller","volume":"15","author":"Eswar","year":"2006","journal-title":"Curr. Protoc. Bioinformatics"},{"issue":"1","key":"10.1016\/j.lfs.2021.119193_bb0145","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1006\/jmbi.1996.0628","article-title":"Deviations from standard atomic volumes as a quality measure for protein crystal structures","volume":"264","author":"Pontius","year":"1996","journal-title":"J. Mol. Biol."},{"issue":"13","key":"10.1016\/j.lfs.2021.119193_bb0150","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.lfs.2021.119193_bb0155","unstructured":"The PyMOL Molecular Graphics System, Schr\u00f6dinger, LLC."},{"key":"10.1016\/j.lfs.2021.119193_bb0160","doi-asserted-by":"crossref","unstructured":"O'Boyle, N.M., et al., Open babel: an open chemical toolbox. J Cheminform, 2011. 3: p. 33.","DOI":"10.1186\/1758-2946-3-33"},{"issue":"16","key":"10.1016\/j.lfs.2021.119193_bb0165","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.lfs.2021.119193_bb0170","doi-asserted-by":"crossref","unstructured":"Neudert, G. and G. Klebe, DSX: a knowledge-based scoring function for the assessment of protein-ligand complexes. J. Chem. Inf. Model., 2011. 51(10): p. 2731\u201345.","DOI":"10.1021\/ci200274q"},{"issue":"Web Server issue","key":"10.1016\/j.lfs.2021.119193_bb0175","doi-asserted-by":"crossref","first-page":"W522","DOI":"10.1093\/nar\/gkm276","article-title":"PDB2PQR: expanding and upgrading automated preparation of biomolecular structures for molecular simulations","volume":"35","author":"Dolinsky","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2021.119193_bb0180","unstructured":"Case, D.A., et al., AMBER 2018, University of California, San Francisco. 2018."},{"key":"10.1016\/j.lfs.2021.119193_bb0185","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/1756-0500-5-367","article-title":"ACPYPE - AnteChamber PYthon Parser interfacE","volume":"5","author":"Sousa da Silva","year":"2012","journal-title":"BMC Res Notes"},{"key":"10.1016\/j.lfs.2021.119193_bb0190","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"3","key":"10.1016\/j.lfs.2021.119193_bb0195","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comput. Phys."},{"key":"10.1016\/j.lfs.2021.119193_bb0200","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1063\/1.434317","article-title":"Brownian dynamics: its application to ionic solutions","volume":"66","author":"Turq","year":"1977","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.lfs.2021.119193_bb0205","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.lfs.2021.119193_bb0210","doi-asserted-by":"crossref","unstructured":"Humphrey, W., A. Dalke, and K. Schulten, VMD: visual molecular dynamics. Journal of Molecular Graphics & Modelling, 1996. 14(1): p. 33\u201338.","DOI":"10.1016\/0263-7855(96)00018-5"},{"issue":"7","key":"10.1016\/j.lfs.2021.119193_bb0215","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1021\/ct400341p","article-title":"PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data","volume":"9","author":"Roe","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.lfs.2021.119193_bb0220","series-title":"R: A Language and Environment for Statistical Computing","author":"(2020), R.C.T","year":"2020"},{"key":"10.1016\/j.lfs.2021.119193_bb0225","series-title":"ggplot2: Elegant Graphics for Data Analysis","author":"Wickham","year":"2016"},{"issue":"3","key":"10.1016\/j.lfs.2021.119193_bb0230","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1681\/ASN.2006111218","article-title":"Identification of a forskolin-like molecule in human renal cysts","volume":"18","author":"Putnam","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119193_bb0235","doi-asserted-by":"crossref","first-page":"F446","DOI":"10.1152\/ajprenal.90415.2008","article-title":"cAMP-dependent chloride secretion mediates tubule enlargement and cyst formation by cultured mammalian collecting duct cells","volume":"296","author":"Montesano","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.lfs.2021.119193_bb0245","doi-asserted-by":"crossref","unstructured":"Vanden Berghe, T., et al., Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol, 2014. 15(2): p. 135\u201347.","DOI":"10.1038\/nrm3737"},{"key":"10.1016\/j.lfs.2021.119193_bb0250","doi-asserted-by":"crossref","unstructured":"Huang, H.S., et al., Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors. Kidney Int., 2006. 70(4): p. 699\u2013710.","DOI":"10.1038\/sj.ki.5001651"},{"key":"10.1016\/j.lfs.2021.119193_bb0255","doi-asserted-by":"crossref","unstructured":"Mulay, S.R., et al., How kidney cell death induces renal necroinflammation. Semin. Nephrol., 2016. 36(3): p. 162\u201373.","DOI":"10.1016\/j.semnephrol.2016.03.004"},{"issue":"1","key":"10.1016\/j.lfs.2021.119193_bb0260","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1681\/ASN.2015040405","article-title":"Necroinflammation in kidney disease","volume":"27","author":"Mulay","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.lfs.2021.119193_bb0265","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-0936-8","article-title":"RIPK3-MLKL-mediated necroinflammation contributes to AKI progression to CKD","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.lfs.2021.119193_bb0275","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jcc.20634","article-title":"A semiempirical free energy force field with charge-based desolvation","volume":"28","author":"Huey","year":"2007","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2021.119193_bb0280","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.lfs.2021.119193_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/s42004-019-0205-5","article-title":"An investigation of structural stability in protein-ligand complexes reveals the balance between order and disorder","volume":"2","author":"Majewski","year":"2019","journal-title":"Communications Chemistry"},{"key":"10.1016\/j.lfs.2021.119193_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105424","article-title":"An insight into the therapeutic applications of coumarin compounds and their mechanisms of action","volume":"152","author":"Garg","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2021.119193_bb0295","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/1675957","article-title":"Coumarins as modulators of the Keap1\/Nrf2\/ARE signaling pathway","volume":"2020","author":"Hassanein","year":"2020","journal-title":"Oxidative Med. Cell. Longev."},{"issue":"16","key":"10.1016\/j.lfs.2021.119193_bb0300","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.7150\/thno.44054","article-title":"Sulforaphane elicts dual therapeutic effects on renal inflammatory injury and crystal deposition in calcium oxalate nephrocalcinosis","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2021.119193_bb0305","doi-asserted-by":"crossref","unstructured":"Xi, J., et al., SIRT3 inhibited the formation of calcium oxalate-induced kidney stones through regulating NRF2\/HO-1 signaling pathway. J. Cell. Biochem., 2018.","DOI":"10.1002\/jcb.28109"},{"key":"10.1016\/j.lfs.2021.119193_bb0310","doi-asserted-by":"crossref","unstructured":"Rush, B.M., et al., Genetic or pharmacologic Nrf2 activation increases proteinuria in chronic kidney disease in mice. Kidney Int., 2020.","DOI":"10.1016\/j.kint.2020.07.036"},{"issue":"26","key":"10.1016\/j.lfs.2021.119193_bb0315","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2021.119193_bb0320","doi-asserted-by":"crossref","unstructured":"Mulay, S.R. and H.J. Anders, Crystallopathies. N. Engl. J. Med., 2016. 374(25): p. 2465\u201376.","DOI":"10.1056\/NEJMra1601611"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521001788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521001788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:47:08Z","timestamp":1758401228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521001788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":62,"alternative-id":["S0024320521001788"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119193","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"6,7-Dihydroxycoumarin ameliorates crystal-induced necroptosis during crystal nephropathies by inhibiting MLKL phosphorylation","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119193"}}